Drugs & TargetsFree Opdivo + Yervoy receive FDA approval combined with limited chemotherapy as first-line treatment of metastatic or recurrent NSCLC May 29, 2020Vol.46 No.22
Drugs & TargetsFree Brigatinib receives FDA approval for ALK-positive metastatic NSCLC May 29, 2020Vol.46 No.22
Drugs & TargetsFree CLR 131 receives fast track designation in lymphoplasmacytic lymphoma/Waldenstrom’s macroglobulinemia May 29, 2020Vol.46 No.22
Clinical RoundupFree Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma May 29, 2020Vol.46 No.22
Clinical RoundupFree Fox Chase researchers investigate perceived barriers to discussing sexual issues in breast cancer patients May 29, 2020Vol.46 No.22
Clinical RoundupFree Evidence from two studies demonstrates efficacy of Immunoscore May 29, 2020Vol.46 No.22
Clinical RoundupFree MK-6482 induced positive response in Hippel-Lindau disease–associated kidney cancer May 29, 2020Vol.46 No.22
FreeIn Brief Catherine Alfano, Stacy Sanchez, Joseph Herman, Martin Karpeh recruited by Northwell Cancer Institute May 29, 2020Vol.46 No.22
FreeIn Brief Pamela Hull joins Markey as associate director of population science and community impact May 29, 2020Vol.46 No.22
